Cargando…
Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such margin...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368804/ https://www.ncbi.nlm.nih.gov/pubmed/30736744 http://dx.doi.org/10.1186/s12876-019-0939-7 |
_version_ | 1783394067922550784 |
---|---|
author | Uto, Keiichi Sakamoto, Seisuke Que, Weitao Shimata, Keita Hashimoto, Shintaro Sakisaka, Masataka Narita, Yasuko Yoshii, Daiki Zhong, Lin Komohara, Yoshihiro Li, Xiao-Kang Inomata, Yukihiro Hibi, Taizo |
author_facet | Uto, Keiichi Sakamoto, Seisuke Que, Weitao Shimata, Keita Hashimoto, Shintaro Sakisaka, Masataka Narita, Yasuko Yoshii, Daiki Zhong, Lin Komohara, Yoshihiro Li, Xiao-Kang Inomata, Yukihiro Hibi, Taizo |
author_sort | Uto, Keiichi |
collection | PubMed |
description | BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats. METHODS: We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated. RESULTS: The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3–12 per group, P < 0.05). CONCLUSIONS: Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-019-0939-7) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6368804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-63688042019-02-15 Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation Uto, Keiichi Sakamoto, Seisuke Que, Weitao Shimata, Keita Hashimoto, Shintaro Sakisaka, Masataka Narita, Yasuko Yoshii, Daiki Zhong, Lin Komohara, Yoshihiro Li, Xiao-Kang Inomata, Yukihiro Hibi, Taizo BMC Gastroenterol Research Article BACKGROUND: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such marginal donors is therefore crucial for reducing the possibility of the primary non-function of grafts and graft loss. Some reports have found that molecular-hydrogen showed antioxidant and anti-inflammatory effects in preventing IRI in some non-hepatic transplant models. Therefore, we investigated whether or not molecular-hydrogen could attenuate IRI in LT model rats. METHODS: We used a hydrogen-rich water bath to dissolve hydrogen into solution and graft tissues and performed isogenic and orthotopic LT in Lewis rats with University of Wisconsin (UW) solution. Blood and tissue samples were collected 6 h after the reperfusion. Hepatic enzymes in serum were measured. Pathological findings including the expressions of cytokines and heme oxygenase (HO)-1 in liver tissues were evaluated. RESULTS: The concentration of hydrogen inside the graft tissues increased depending on the storage time, plateauing after 1 h. Serum liver enzyme levels were significantly lower and the histology score of liver damage markedly attenuated in the group given grafts preserved in hydrogen-rich UW solution than in the control group. The hydrogen-rich UW solution group also showed less oxidative damage and hepatocyte apoptosis than the control group, and the expression of proinflammatory cytokines tended to be lower while the protein levels of HO-1 were significantly increased (n = 3–12 per group, P < 0.05). CONCLUSIONS: Storage of liver grafts in hydrogen-rich UW solution resulted in superior functional and morphologic protection against IRI via the up-regulation of HO-1 expression. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12876-019-0939-7) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-08 /pmc/articles/PMC6368804/ /pubmed/30736744 http://dx.doi.org/10.1186/s12876-019-0939-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Uto, Keiichi Sakamoto, Seisuke Que, Weitao Shimata, Keita Hashimoto, Shintaro Sakisaka, Masataka Narita, Yasuko Yoshii, Daiki Zhong, Lin Komohara, Yoshihiro Li, Xiao-Kang Inomata, Yukihiro Hibi, Taizo Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title | Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title_full | Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title_fullStr | Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title_full_unstemmed | Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title_short | Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
title_sort | hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368804/ https://www.ncbi.nlm.nih.gov/pubmed/30736744 http://dx.doi.org/10.1186/s12876-019-0939-7 |
work_keys_str_mv | AT utokeiichi hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT sakamotoseisuke hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT queweitao hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT shimatakeita hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT hashimotoshintaro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT sakisakamasataka hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT naritayasuko hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT yoshiidaiki hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT zhonglin hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT komoharayoshihiro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT lixiaokang hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT inomatayukihiro hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation AT hibitaizo hydrogenrichsolutionattenuatescoldischemiareperfusioninjuryinratlivertransplantation |